SI
Sofinnova Investments’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 57 |
|
|
2022
Q2 | – | Sell |
-547,441
| Closed | -$13M | – | 63 |
|
|
2022
Q1 | $13M | Buy |
547,441
+65,184
| +14% | +$1.54M | 0.98% | 23 |
|
|
2021
Q4 | $16.5M | Buy |
482,257
+184,548
| +62% | +$6.31M | 0.96% | 24 |
|
|
2021
Q3 | $5.28M | Sell |
297,709
-151,373
| -34% | -$2.68M | 0.31% | 49 |
|
|
2021
Q2 | $20.2M | Sell |
449,082
-205,818
| -31% | -$9.24M | 1.16% | 21 |
|
|
2021
Q1 | $17M | Buy |
+654,900
| New | +$17M | 1.02% | 25 |
|
|
2020
Q4 | – | Sell |
-357,769
| Closed | -$6.99M | – | 73 |
|
|
2020
Q3 | $6.99M | Buy |
357,769
+31,705
| +10% | +$620K | 0.52% | 30 |
|
|
2020
Q2 | $5.76M | Buy |
+326,064
| New | +$5.76M | 0.36% | 45 |
|